Bacterial postbiotics as promising tools to mitigate cardiometabolic diseases

Research output: Contribution to journalJournal articleResearchpeer-review


Gut microbes dictate critical features of host immunometabolism. Certain bacterial components and metabolites (termed postbiotics) mitigate cardiometabolic diseases whereas others potentiate pathological processes. In this review, we discuss key aspects related to the usefulness of bacterial-related molecules strategically positioned as promising treatment strategies for cardiometabolic diseases.

Original languageEnglish
JournalJournal of Lipid and Atherosclerosis
Issue number2
Pages (from-to)123-129
Number of pages7
Publication statusPublished - 2021

Bibliographical note

Publisher Copyright:
© 2021 The Korean Society of Lipid and Atherosclerosis.

    Research areas

  • Akkermansia, Diabetes mellitus, type 2, Lipopolysaccharides, Obesity, Peptidoglycan

ID: 285449134